Abstract:Capillary electrophoresis/mass spectrometry (CE/MS) is predominantly carried out using electrospray ionization (ESI). Recently, atmospheric pressure chemical ionization (APCI) and atmospheric pressure photoionization (APPI) have become available for CE/MS. With the VUV lamp turned off, the APPI source may also be used for CE/MS by thermospray ionization (TSI). In the present study the suitability of ESI, APCI, APPI and TSI for drug impurity profiling by CE/MS in the positive ion mode is evaluated. The drugs carbachol, lidocaine and proguanil and their potential impurities were used as test compounds, representing different molecular polarities. A background electrolyte of 100 mM acetic acid (pH 4.5) provided baseline separation of nearly all impurities from the respective drugs. APPI yielded both even- and odd-electron ions, whereas the other ionization techniques produced even-electron ions only. In-source fragmentation was more pronounced with APCI and APPI than with ESI and TSI, which was most obvious for proguanil and its impurities. In general, ESI and TSI appeared the most efficient ionization techniques for impurities that are charged in solution achieving detection limits of 100 ng/mL (full-scan mode). APPI and APCI showed a lower efficiency, but allowed ionization of low and high polarity analytes, although quaternary ammonium compounds (e.g. carbachol) could not be detected. Largely neutral compounds, such as the lidocaine impurity 2,6-dimethylaniline, could not be detected by TSI, and yielded similar detection limits (500 ng/mL) for ESI, APPI and APCI. In many cases, impurity detection at the 0.1% (w/w) level was possible when 1 mg/mL of parent drug was injected with at least one of the CE/MS systems. Overall, the tested CE/MS systems provide complementary information as illustrated by the detection and identification of an unknown impurity in carbachol.

Identification of Impurities in 3-Chloro-10,11-dihydro-5H-dibenz[b,f]azepine by Gas Chromatography-Mass Spectrometry

Novel Synthesis Process of 5H-Dibenz[b,f]azepine and Removal of Chloroformyl Protection Group

ASE- GC Determination of Residual Solvents in Extracts of Herba Epimedii

Identification of impurities in 6-bromo-methandrostenolone by gas chromatography-mass spectrometry

Separation and Characterization of Synthetic Impurities of Triclabendazole by Reversed-Phase High-Performance Liquid Chromatography/electrospray Ionization Mass Spectrometry

Characterization of Impurities in the Bulk Drug Lisinopril by Liquid Chromatography/ion Trap Spectrometry

[Determination of Impurities in a Technical Chlorpyrifos by Gas Chromatography with Atomic Emission Detection].

Chromatographic Fingerprint for Schizonepeta Tenuisfolia Briq.

Separation and characterization of the impurities in 3,3-diamino-4,4-azoxyfurazan by ultrahigh-performance liquid chromatography combined with Q‐orbitrap mass spectrometry

Identification of Chemical Constituents in Guizhi Decoction by High Performance Liquid Chromatography/Electrospray Ionization-Ion Trap-Time-of-Flight Mass Spectrometry

Separation and Characterization of Impurity Pin Azithromycin Product

Analysis of Cyphenothrin and its Impurities in Technical Material by GC-MS

Mass Spectral Fragmentation of Cis- and Trans-1A,3-disubstituted 1, 1-Dichloro-1a,2,3,4-tetrahydro-1h-azirino[1,2-a] [1, 5]Benzodiazepines.

Detection, identification, characterization, and high-performance liquid chromatography quantification of five impurities from a methazolamide product

Mass Spectral Fragmentation Patterns of 1A,3-Diaryl-1,1,4,4-tetrachloro-1a,2,3,4-tetrahydro-1h-azirino[2,1-e][1,6]benzothiazocines

Identification of an Unknown Trace-Level Impurity in Bulk Drug of Seroquel by High-Performance Liquid Chromatography Combined with Mass Spectrometry

Drug impurity profiling by capillary electrophoresis/mass spectrometry using various ionization techniques

Separation and Quantification of Imidazoles in Atmospheric Particles Using LC-Orbitrap-MS.

Mass Spectrometric Studies of Cis- and Trans-1a,3-Disubstituted-1,1-Dichloro-4-Formyl-1a, 2,3,4-Tetrahydro-1h-azirino [1,2-A] [1,5]Benzodiazepines

Identification of the Impurities in Hydroquinone Bis(2-hydroxyethyl)ether Industrial Products by Gas Chromatography-Time of Flight Mass Spectrometry

Determination of Ziprasidone Hydrochloride and Related Substances by Reversed-phase High Performance Liquid Chromatography